Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
FROM THE CHIEF EXECUTIVE OFFICER: AUA Innovation Nexus Inaugural Event
By: Michael T. Sheppard, CPA, CAE | Posted on: 02 Feb 2023
AUA Innovation Nexus, the urology research incubator powered by the AUA, will hold its inaugural event on Thursday, April 27, 2023, prior to the AUA Annual Meeting in Chicago, Illinois. This 1-day event gives start-ups, entrepreneurs, venture capitalists, investors, and urologists the opportunity to come together to ignite urological discovery like never before. Visit auanexus.org to learn more.
Program Highlights
The inaugural event will include a keynote address by Charlie Gasparino, senior correspondent for Fox Business Network and best-selling author, followed by 4 main components: a showcase, reverse pitch, discussion forums, and networking opportunities.
During the Showcase, a select group of the most innovative investigators, start-ups, and midsize companies will have the opportunity to pitch their innovations to a panel of seasoned investors and successful innovators. Presenters will give a presentation followed by a moderated Q&A session with a panel of seasoned strategists, investors, and urology researchers. The Showcase provides the space for entrepreneurs to share their innovations with the perfect audience, get feedback, and make the connections needed to accelerate funding and commercialization. The Showcase will be moderated by Charlie Gasparino and feature panelists Amarpreet S. Sawhney, PhD, CEO of Instylla, Rejoni and Pramand; Kevin Slawin, MD, founder and managing partner of Rapha Capital Management; and Jennie Xue, managing director of Guggenheim Securities.
The Reverse Pitch allows established players in urology discovery to share where their interests lie, what they hope to invest in, and the unanswered questions they are interested in exploring. This unique format gives strategists, venture capitalists, and key investors the opportunity to explain the real-world business challenges they would like to see addressed and the kinds of problems they are interested in collaborating to solve. The reverse pitches will be moderated by Jennie Xue.
Our discussion forums will bring together key opinion leaders in urological discovery—from seasoned entrepreneurs and strategists to venture capitalists and investment bankers. This group of luminaries will discuss thought-provoking topics such as the importance of a urology incubator, current physician and patient needs, investment in urological discovery, and more.
AUA Innovation Nexus is a powerful forum for building the connections needed to move to the next level of innovation and implementation.
We hope you’ll join us for a full day of sharing expertise, learning, ideation, and networking. Visit auanexus.org for more information and to register.
advertisement
advertisement